Category: CovidienSyndicate content

Covidien study: VenaSeal effective in treating leg veins

November 17, 2014 by Val Kennedy

A Covidien study has shown that its new VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.

Covidien study: VenaSeal effective in treating leg veins

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Medtronic readies $10B bond flotation for Covidien deal

November 17, 2014 by Brad Perriello

Medtronic is reportedly preparing to float $10 billion worth of bonds to help fund its $43 billion acquisition of Covidien.

Report: Medtronic readies $10B bond flotation for Covidien deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MDT inks package of loans worth more than $16B to back its $43B acquisition of COV | Medtech Wall Street news for the week of November 10, 2014

November 13, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic inks $16B loan package for Covidien buyout; Second Sight eyes $32m IPO; The silver lining for healthcare in U.S. inversion rules; Survey: Hospitals clamp down on medical device expenses; Nevro boosts IPO to $126m

Medtronic inks $16B loan package for Covidien buyout

November 10, 2014 by Brad Perriello

Medtronic inks package of loans worth more than $16 billion to back its $43 billion acquisition of Covidien | The week in medtech M&A

November 12, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic inks $16B loan package for Covidien buyout; The silver lining for healthcare in U.S. inversion rules; SV Life Sciences buys majority stake in Ximedica; Wright Medical slashes losses, Q3 sales surge; Salix inventory snafu sinks deal with Allergan

Medtronic inks $16B loan package for Covidien buyout

November 10, 2014 by Brad Perriello

Medtronic offers EU concessions in $43 billion Covidien deal

November 11, 2014 by MassDevice

Medtronic agrees to concessions to mollify European anti-trust regulators over its $43 billion buyout of Covidien.

Medtronic offers EU concessions in $43 billion Covidien deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Dr. Tom Fogarty: Venture capital is dead and it's starting to stink

November 10, 2014 by Brian Johnson

The director of the Fogarty Institute, medtech legend Dr. Tom Fogarty, shoots off some fireworks at MassMEDIC's 18th annual Medtech Showcase.

Dr. Tom Fogarty: Venture is dead and it's starting to stink

In the 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that's now the standard of care, he's founded more than 30 medical device startups, placing him among the most prolific inventors in the biomedical space.

Forgarty is also, without a doubt, the industry's best quote.

Medtronic inks $16B loan package for Covidien buyout

November 10, 2014 by Brad Perriello

Medtronic inks a package of loans worth more than $16 billion to back its $43 billion acquisition of Covidien.

Medtronic inks $16B loan package for Covidien buyout

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp